Shire Raises Guidance After Record Sales Growth

Dublin-based drug maker Shire revised its earnings guidance after record sales growth, only a week after U.S. peer AbbVie pulled out of a $54 billion takeover.



from WSJ.com: US Business http://ift.tt/1xhdiqJ

via IFTTT